Real-World check: ovarian cancer drug niraparib under the microscope

NCT ID NCT04295577

Completed Knowledge-focused Sponsor: Royal Marsden NHS Foundation Trust Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked back at 388 women with advanced ovarian, fallopian tube, or peritoneal cancer who were taking the drug niraparib as maintenance therapy. Researchers wanted to see how often serious side effects happened and how patients used the drug in real-life UK clinics. No new treatment was given; it simply observed what happened during routine care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FALLOPIAN TUBE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fallopian tube cancer fallopian tube neoplasm ovarian cancer peritoneum cancer primary peritoneal carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FALLOPIAN TUBE CANCER OVARIAN CANCER PERITONEAL CANCER

Contacts and locations

Locations

Addenbrookes Hospital

Cambridge, CB2 0QQ, United Kingdom
Barts Health NHS Trust

London, E1 1FR, United Kingdom
Belfast Health & Social Care Trust

Belfast, BT9 7AB, United Kingdom
Morecambe Bay NHS Trust

Lancaster, United Kingdom
Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust

Northwood, HA6 2RN, United Kingdom
Northampton General Hospital NHS Trust

Northampton, NN1 5BD, United Kingdom
Queen's Hospital

Romford, RM7 0AG, United Kingdom
Royal Cornwall Hospitals NHS Trust

Truro, TR1 3LJ, United Kingdom
Royal Marsden NHS Foundation Trust

Sutton, SM2 5PT, United Kingdom
Royal United Hospitals Bath

Bath, BA1 3NG, United Kingdom
St James's University Hospital

Leeds, LS9 7TF, United Kingdom
University Hospital Southampton NHS Foundation Trust

Southampton, SO16 5YA, United Kingdom
University Hospitals Birmingham NHS Foundation Trust

Birmingham, B15 2TH, United Kingdom
University Hospitals Bristol NHS Foundation Trust

Bristol, BS2 8ED, United Kingdom
Velindre Cancer Centre, Velindre University NHS Trust

Cardiff, CF14 2TL, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.